Increasing risk of 5% or greater unintentional weight loss in a cohort of HIV-infected patients, 1995 to 2003

Article Abstract:

The six-month risk and determinants of greater than or equal to 5% weight loss during the period when the use of combination antiretroviral therapy and highly active antiretroviral therapy (HAART) was commonplace among participants of a cohort study in Boston between 1995 and 2003, was examined. Findings reveal that the risk of greater than or equal to 5% unintentional weight loss over 6-month intervals is on the rise in cohort of HIV-infected participants, despite better control of HIV infection.

Causes of, Complications and side effects, Weight loss, Dosage and administration

---

Incidence of metabolic syndrome in a cohort of HIV-infected adults and prevalence relative to the US population (National Health ad Nutrition Examination Survey)

Article Abstract:

A study was conducted to determine the incidence and risk factors for metabolic syndrome in HIV-infected adults in the Nutrition for Health Living (NFHL) study and prevalence relative to the findings of the National Health and Nutrition Examination Survey (NHANES). It was found that almost one quarter of NFHL subjects had metabolic syndrome.

United States, Risk factors, Surveys, HIV infection, HIV infections, Metabolic syndrome X, Survey

---

Pathogenesis and consequences of HIV-associated wasting

Article Abstract:

Systematic strategies for monitoring HIV-positive patients for wasting is needed with prophylaxis and treatment offered as appropriate. It is found that for many individuals, highly active antiretroviral therapy (HAART) results in sustained control of HIV, but it may not provide protection against weight loss and HIV-associated wasting.

HIV seropositivity, HIV positive, HIV wasting syndrome

Similar abstracts:

• Abstracts: Incidence and risk factors for weight loss during dual HIV/hepatitis C virus therapy. A tale of 2 epidemics: The intersection between obesity and HIV infection in Philadelphia
• Abstracts: Continuing education: balancing team development in four directions. Forming an interdisciplinary team: a key element in practicing with confidence and efficiency
• Abstracts: Efficacy and safety of a once-daily fixed-dose combination of abacavir twice daily and lamivudine once daily as separate entities in antiretroviral-experienced HIV-1-infected patients (CAL3001 study)

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.